Order

Size
Price
Stock
Qty

Special Offers

Size
Price
Stock
Qty

FRAX 486

Axon 2331
CAS:  1232030-35-1
Purity:  99%
  • Soluble in DMSO
  • MF:  C25H23Cl2FN6O
  • MW:  513.39

Description

FRAX 486 is a bioavailable and brain-penetrant group I p21-activated kinase (PAK) inhibitor with IC50 values of 8.25 nM, 39.5 nM and 55.3 nM for PAK1, PAK2 and PAK3, respectively. It shows selectivity over PAK4 and rescues dendritic spine and behavioral phenotypes in Fmr1 knockout models.

Group I PAKs link Rac/Cdc42 GTPase signaling to cytoskeletal remodeling, synaptic structure and neurodevelopmental phenotypes. FRAX 486 is useful for studying PAK-dependent neuronal morphology, Fragile X syndrome biology and neuropsychiatric disease mechanisms.

Key Features

  • Brain-penetrant group I PAK inhibitor
  • IC50: 8.25 nM at PAK1
  • Inhibits PAK2 and PAK3 in the low-nanomolar range
  • Rescues dendritic spine phenotypes in Fmr1 models

Applications

  • PAK kinase pharmacology
  • Fragile X syndrome model studies
  • Dendritic spine morphology assays
  • Neurodevelopmental and synaptic signaling research

More Information

Parent CAS No. 1232030-35-1
Chemical Name 6-(2,4-dichlorophenyl)-8-ethyl-2-(3-fluoro-4-(piperazin-1-yl)phenylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
SMILES C1(NC2=CC=C(N3CCNCC3)C(F)=C2)=NC=C2C=C(C3=CC=C(Cl)C=C3Cl)C(=O)N(CC)C2=N1
MFCD N.A.
InChi InChI=1S/C25H23Cl2FN6O/c1-2-34-23-15(11-19(24(34)35)18-5-3-16(26)12-20(18)27)14-30-25(32-23)31-17-4-6-22(21(28)13-17)33-9-7-29-8-10-33/h3-6,11-14,29H,2,7-10H2,1H3,(H,30,31,32)
InChiKey DHKFOIHIUYFSOF-UHFFFAOYSA-N
CID 68060125
Short Description PAK inhibitor

Related Products

AXON ID NAME FROM PRICE
1167 GSK 269962A

From $77.00

1485 Fingolimod

From $66.00

1535 Thiazovivin

From $99.00

1578 NSC 23766

From $121.00

1676 BXL 628

From $176.00

1683 Y 27632 dihydrochloride

From $71.50

2138 ZCL 278

From $115.50

2187 AS 1892802

From $104.50

2229 RKI 1447

From $115.50

2351 EHop 016

From $93.50

2669 AZ13705339

From $137.50

3557 KPT-9274

From $143.00

3961 PF-03758309

From Inquiry

Loading...